The DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index; 115 of the 206 sources its claims cite were checked for support.
Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model
Open accessAbstract
Chronic stress and depressive-like behaviors in basic neuroscience research have been associated with impairments of neuroplasticity, such as neuronal atrophy and synaptic loss in the medial prefrontal cortex (mPFC) and hippocampus. The current review presents a novel integrative model of neuroplasticity as a multi-domain neurobiological, cognitive, and psychological construct relevant in depression and other related disorders of negative affect (e.g., anxiety). We delineate a working conceptual model in which synaptic plasticity deficits described in animal models are integrated and conceptually linked with human patient findings from cognitive science and clinical psychology. We review relevant reports including neuroimaging findings (e.g., decreased functional connectivity in prefrontal-limbic circuits), cognitive deficits (e.g., executive function and memory impairments), affective information processing patterns (e.g., rigid, negative biases in attention, memory, interpretations, and self-associations), and patient-reported symptoms (perseverative, inflexible thought patterns; inflexible and maladaptive behaviors). Finally, we incorporate discussion of integrative research methods capable of building additional direct empirical support, including using rapid-acting treatments (e.g., ketamine) as a means to test this integrative model by attempting to simultaneously reverse these deficits across levels of analysis.
Overview
CoChat Summary
TL;DR
This integrative review proposes neuroplasticity as a multi-domain construct linking molecular/cellular synaptic deficits in depression to neural network, cognitive, affective information processing, and clinical/self-report levels. It argues that rapid-acting treatments such as ketamine can test the model by simultaneously reversing deficits across these levels.
Key findings
- Depression is associated with robust decreases in hippocampal and PFC volumes; large imaging corpuses including >1000 unipolar depressed patients and many thousands of healthy controls documented particularly robust hippocampal volume decreases, driven by recurrent depression and early age of onset (≤age 21). Amygdalar volume decreases were seen only in early-onset depression and were not statistically robust after multiple-comparison correction; robust cortical thickness decreases were observed in medial and orbital PFC and anterior cingulate cortex.
- Meta-analytic executive-function findings in depressed patients show pronounced deficits (Cohen’s d ≥1.0) in cognitive flexibility, inhibition capacity, and verbal fluency, plus moderate impairments in strategic planning and organization; attention and concentration are also broadly impaired.
- Ketamine shows well-replicated rapid antidepressant effects in randomized controlled trials (meta-analytic Cohen’s d=1.4), attributed to rapid reversal of neuroplasticity deficits; a single dose increases BDNF release, stimulates mTORC1 signaling, increases synaptic proteins (GluR1, PSD95, synapsin 1), and increases synapse number and function in PFC, with new synapse formation causally related to antidepressant-like actions.
- The proposed model predicts that an agent reversing molecular neuroplasticity deficits should produce correlated, simultaneous reversals across neural network, cognitive, affective information processing, and self-report levels; ketamine findings are presented as preliminary support, including increased PFC connectivity, improved cognitive flexibility, and rapid shifts in implicit self-representations.
Methods
- Narrative/integrative review, not a primary empirical study; it synthesizes findings from basic neuroscience animal models, human neuroimaging, cognitive science, and clinical psychology.
- The paper delineates a working conceptual model across molecular/cellular, neural network, cognitive function, affective information processing, and clinical/self-report levels (Table 1; Figure 1).
- It uses intravenous ketamine as a test case for the model’s falsifiable prediction of simultaneous, correlated reversals across levels of analysis, and discusses experimental manipulation at each level (Table 2).
Limitations
- The paper states that direct empirical links across levels remain quite preliminary (Table 2), and that further integration across multiple markers is needed.
- It notes marked heterogeneity of depressed patients at neural network, cognitive, information processing, and clinical levels, and that no known intervention strategy is effective for all depressed patients.
- It states that ketamine research has focused largely on molecular effects in animal models or symptom-level effects in human patients, that molecular endpoints are difficult to assess in the living brain, and that larger sample sizes are likely needed for individual-differences and mediational investigations. Evident from the text: as a narrative review, it does not report a systematic search strategy or quantitative synthesis.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
66 Valid · 20 Not valid · 33 Not checked · 19 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Convergent data show increased PFC glucose metabolism 24-hours post-ketamine 125,126 , increased fMRI PFC activations acutely (during infusion itself) 127 , and decreased limbic responses to angry (relative to happy) faces among ketamine responders 128 .”
What the sources say
- Partly supportedcites [125] Li CT, Chen MH, Lin WC, Hong CJ, Yang BH, Liu RS, et al. The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study. Hum Brain Mapp. 2016;37:1080–90. sourceExperimental — accuracy not yet measured
The Abstract reports increased prefrontal cortex glucose uptake after ketamine, supporting that part of the claim. The Introduction and Imaging Procedures place the post-ketamine PET measurement about 45–60 minutes after administration, not 24 hours later; the paper therefore does not support the stated timing. Page numbers are unavailable in our copy. (LLM, conf=0.90)
- Disputedcites [126] Ionescu DF, Felicione JM, Gosai A, Cusin C, Shin P, Shapero BG, et al. Ketamine-Associated Brain Changes: a review of the neuroimaging literature. Harv Rev Psychiatry. 2018;26:320–39. sourceExperimental — accuracy not yet measured
In Results > Ketamine and Neuroimaging in Depression (page unavailable), the review reports decreased metabolism in the right ventrolateral and dorsolateral PFC at 120 minutes post-ketamine, rather than an increase. The Discussion says convergence on a specific brain area is elusive; our copy does not report increased PFC glucose metabolism at 24 hours. (LLM, conf=0.79)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“In small, uncontrolled samples, convergent findings in depressed patients further suggest cognitive flexibility on objective cognitive tests improves acutely following ketamine 132,133 .”
What the sources say
- Disputedcites [132] Shiroma PR, Albott CS, Johns B, Thuras P, Wels J, Lim KO. Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression. Int J Neuropsychopharmacol. 2014;17:1805–13. sourceExperimental — accuracy not yet measured
The Results section ('Neurocognitive effects of six ketamine infusions'; page not provided) reports significant improvements in visual and working memory, but says all other cognitive tasks showed nonsignificant changes. The paper identifies set shifting as a tested domain, so it does not report an acute improvement in cognitive flexibility. (LLM, conf=0.85)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [133] Permoda-Osip A, Kisielewski J, Bartkowska-Sniatkowska A, Rybakowski JK. Single ketamine infusion and neurocognitive performance in bipolar depression. Pharmacopsychiatry. 2015;48:78–9. source
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Two studies in rats 130,131 extend molecular findings in animal models to behavioral indices with possible relevance to cognitive flexibility in human patients.”
What the sources say
- Supportedcites [130] Jett JD, Boley AM, Girotti M, Shah A, Lodge DJ, Morilak DA. Antidepressant-like cognitive and behavioral effects of acute ketamine administration associated with plasticity in the ventral hippocampus to medial prefrontal cortex pathway. Psychopharmacology. 2015;232:3123–33. source
The Methods identify the study animals as rats, and the Results (Ketamine and AST; page unavailable) report that ketamine restored stress-impaired performance on a behavioral test of cognitive flexibility. The Discussion (page unavailable) connects these effects to glutamate signaling and plasticity and discusses their possible relevance to depressed patients. This paper supports the claim as one of the two cited rat studies; it does not need to establish what the other study found. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [131] Nikiforuk A, Popik P. Ketamine prevents stress-induced cognitive inflexibility in rats. Psychoneuroendocrinology. 2014;40:119–22. source
states an associationn = 2- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Repeated stress decreases the expression of BDNF in limbic and cortical brain regions, notably the hippocampus and PFC 4,5,22 .”
What the sources say
- Supportedcites [4] Duman RS, Aghajanian GK, Sanacora G, Krystal JH. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med. 2016;22:238–49. sourceExperimental — accuracy not yet measured
The section on reduced neurotrophic factor expression (page not available in our copy) reports that stress lowers BDNF expression in the prefrontal cortex and hippocampus. The paper also discusses repeated stress as harmful to the brain, consistent with the citing sentence’s framing. (LLM, conf=0.90)
- Supportedcites [5] Duman RS, Aghajanian GK. Synaptic dysfunction in depression: potential therapeutic targets. Science. 2012;338:68–72. sourceExperimental — accuracy not yet measured
In the “Alterations of brain-derived neurotrophic factor (BDNF)” passage, the paper states that stress or glucocorticoid exposure decreases BDNF expression in the hippocampus and PFC. Its discussion of chronic stress provides context for the citing sentence’s reference to repeated stress. (LLM, conf=0.91)
- Partly supportedcites [22] Duman RS, Sanacora G, Krystal JH. Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron. 2019;102:75–90. sourceExperimental — accuracy not yet measured
The “GABA alterations in MDD and stress” section says stress reduces BDNF and reports that chronic stress lowers certain BDNF mRNA isoforms, in context of findings about the PFC. The “Stress and neurotrophic factors” section reports lower BDNF in the hippocampus and PFC of people with depression, but does not establish that repeated stress caused the hippocampal decrease. Page numbers are unavailable in our copy. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The rapidity and magnitude of ketamine's effects have been attributed to its ability to rapidly reverse neuroplasticity deficits in animal models 3,4,10,34 .”
What the sources say
- Supportedcites [3] Abdallah CG, Sanacora G, Duman RS, Krystal JH. Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics. Annu Rev Med. 2015;66:509–23. source
The Introduction describes ketamine’s rapid and potent antidepressant effects. In “Synaptogenesis and the Rapid Antidepressant Effects of Ketamine” (page unavailable), the review describes rodent studies of rapid synaptic changes and says ketamine’s acute effects oppose stress-induced neuronal atrophy and synaptic dysconnectivity. This supports the proposed explanation, without establishing it as the sole mechanism. (LLM, conf=0.92)
- Supportedcites [4] Duman RS, Aghajanian GK, Sanacora G, Krystal JH. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med. 2016;22:238–49. source
The “Rapid acting antidepressants: mechanism of action” section (page not provided) reports that a single dose of ketamine rapidly reverses morphological and behavioral deficits in a mouse chronic-stress model. It also links ketamine’s rapid synaptic changes to its antidepressant behavioral effects, supporting the attributed explanation. (LLM, conf=0.92)
- Partly supportedcites [10] Moda-Sava RN, Murdock MH, Parekh PK, Fetcho RN, Huang BS, Huynh TN, et al. Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation. Science. 2019;364:eaat8078. sourceExperimental — accuracy not yet measured
The Results report that ketamine rescued stress-related spine loss in mice, supporting the neuroplasticity-reversal part of the claim. But the Results section on prefrontal spinogenesis says behavioral effects began at 3 hours, before spine formation increased at 12–24 hours; spine formation was not required for the acute effect. This paper therefore does not support attributing the rapidity of ketamine’s effects to spine restoration, and it does not establish that mechanism as an explanation for their magnitude. (LLM, conf=0.88)
- Partly supportedcites [34] Zanos P, Moaddel R, Morris PJ, Georgiou P, Fischell J, Elmer GI, et al. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature. 2016;533:481–6. sourceExperimental — accuracy not yet measured
The Introduction describes ketamine’s rapid, robust antidepressant effects, and the Discussion links its metabolite’s antidepressant actions to changes in synaptic signaling and AMPA receptors. But the paper does not show that ketamine rapidly reverses pre-existing neuroplasticity deficits in animal models, so it does not establish the proposed explanation for the effects’ rapidity and magnitude. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
66 more claims · 36 with their cited sources checked
Create a free account to see all 138 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 51
- Probably not a substantial claim. 29
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“At the systems scale, deficits in hippocampal and prefrontal plasticity seen in susceptible strains are reversible when interventions reset both synaptic strength and excitability, whether via pharmacology, experience-dependent enrichment, electroconvulsive therapy, or molecular levers such as SIRT1 that couple intrinsic firing properties to synaptic throughput [12,349,399].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [399]
Experimental — accuracy not yet measuredIn the citing paper
“Synaptic plasticity deficits in PFC of animal models have been linked to clinical findings from human patients with frontal cortical dysfunction, including the decreased functional connectivity in prefrontal-limbic circuits, executive function and memory deficits, inflexible and maladaptive behaviors 121.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [121]
In the citing paper
“The hippocampus is of particular importance in understanding depression pathogenesis14-16.”
From Dysregulation of adult hippocampal neuroplasticity in major depression: Pathogenesis and therapeutic implications (2022) · cites this paper as [15]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519 · cited 2×
“The two hallmark mood symptoms of depression—at least one of which is required to diagnose a major depressive episode [110]—are persistent dysphoric mood and persistent anhedonia (the inability to experience pleasure), mirroring the two major forms of information processing bias (positive and negative valence systems)…”
BackgroundRequirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Self-citationPrevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy.
Teasdale, J. D., Segal, Z. V., Williams, J. M. G., Ridgeway, V. A., Soulsby, J. M., & Lau, M. A. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.4.615 · Cited by 3,236
Psychological flexibility as a fundamental aspect of health
Kashdan, T. B., & Rottenberg, J. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.03.001 · Cited by 3,054
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881
Self-citationStorage and Executive Processes in the Frontal Lobes
Smith, E. E., & Jonides, J. (1999) · Science · doi:10.1126/science.283.5408.1657 · Cited by 2,834
Wang, P. S., Lane, M., Olfson, M., Pincus, H. A., Wells, K. B., & Kessler, R. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.629 · Cited by 2,695 · cited 1×
“7% of patients receiving minimally adequate treatment [2].”
BackgroundCognition and Depression: Current Status and Future Directions
Gotlib, I. H., & Joormann, J. (2010) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.121208.131305 · Cited by 2,420
THE AMYGDALA MODULATES THE CONSOLIDATION OF MEMORIES OF EMOTIONALLY AROUSING EXPERIENCES
McGaugh, J. L. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144157 · Cited by 2,296
Research works printed but not linked: 1
- Fuster JM. The prefrontal cortex. 3rd edn. Philadelphia, PA: Lippincott-Raven; 1997.
Cited by
The Semantics of Microglia Activation: Neuroinflammation, Homeostasis, and Stress
Woodburn, S. C., Bollinger, J. L., & Wohleb, E. S. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02309-6 · Cited by 783
Tartt, A. N., Mariani, M. B., Hen, R., Mann, J. J., & Boldrini, M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01520-y · Cited by 408
Hertenstein, E., Trinca, E., Wunderlin, M., Schneider, C. L., Züst, M. A., Fehér, K. D., Su, T., Straten, A. V., Berger, T., Baglioni, C., et al. (2022) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2022.101597 · Cited by 391
Towards an understanding of psychedelic-induced neuroplasticity
Calder, A. E., & Hasler, G. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-022-01389-z · Cited by 313
“Depression in particular is characterized by reduced cortical neuroplasticity [56, 126–128], synapse atrophy in the PFC [18, 129–131], and a reduced ability of the PFC to regulate limbic areas [132, 133].”
BackgroundYan, Z., & Rein, B. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01092-3 · Cited by 300
“…de fi cits in the PFC of animal models have been linked to clinical fi ndings from human patients with frontal cortical dysfunction, including the decreased functional connectivity in prefrontal – limbic circuits, executive function and memory de fi cits, in fl exible and maladaptive behaviors [121].”
Background
Metadata
- Authors
- Price, R. B., & Duman, R.
- Affiliations
- University of Pittsburgh (US)
- Yale University (US)
- Corresponding author
- Price, Rebecca B.
- Venue
- Molecular Psychiatry
- Published
- 2019-12-04
- Volume
- 25
- Issue
- 3
- Pages
- 530-543
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC7047599
- OpenAlex
- W2994049374
- Semantic Scholar
- 8c3f9524303c11409c0eb0c17f79ad14f7f682ab
- Cited by
- 739
- References
- 171
- Citations by year
- 2026: 121 · 2025: 170 · 2024: 158 · 2023: 127 · 2022: 82 · 2021: 60 · 2020: 21
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH113857)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- neuroplasticity, depression, chronic stress, synaptic plasticity, medial prefrontal cortex, hippocampus, negative affect, anxiety, executive function, memory impairment, attentional bias, cognitive biases, ketamine, rapid-acting antidepressants, integrative model
- MeSH terms
- Animals, Brain, Cognition, Cognition Disorders, Depression, Depressive Disorder, Hippocampus, Humans, Memory, Nerve Net, Neuronal Plasticity, Neurons, Stress, Psychological, Prefrontal Cortex, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-02, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-02 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model. https://app.cochat.ai/papers/10.1038/s41380-019-0615-x
- The paper
- Price, R. B., & Duman, R. (2020). Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model. Molecular Psychiatry. https://doi.org/10.1038/s41380-019-0615-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.